These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers. Burkhardt O; Stass H; Thuss U; Borner K; Welte T Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression. Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513 [TBL] [Abstract][Full Text] [Related]
6. Interaction between phenytoin and enteral nutrients and its influence on gastrointestinal absorption. Urashima Y; Urashima K; Ohnishi M; Matsushita K; Suzuki K; Kurachi K; Nishihara M; Katsumata T; Myotoku M; Ikeda K; Hirotani Y Pharmazie; 2019 Sep; 74(9):559-562. PubMed ID: 31484597 [TBL] [Abstract][Full Text] [Related]
7. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy. Aliwarga T; Cloyd JC; Goel V; Brundage RC; Marino SE; Leppik IE; Remmel RP Ther Drug Monit; 2011 Feb; 33(1):56-63. PubMed ID: 21233690 [TBL] [Abstract][Full Text] [Related]
8. Absolute bioavailability of phenytoin after 3-phosphoryloxymethyl phenytoin disodium (ACC-9653) administration to humans. Jamerson BD; Donn KH; Dukes GE; Messenheimer JA; Brouwer KL; Powell JR Epilepsia; 1990; 31(5):592-7. PubMed ID: 2401249 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulation. Randinitis EJ; Buchanan RA; Kinkel AW Epilepsia; 1990; 31(4):458-64. PubMed ID: 2369880 [TBL] [Abstract][Full Text] [Related]
10. Nasogastric administration of garenoxacin as crushed tablets with and without concomitant enteral feeding in healthy subjects. Krishna G; Noveck R; Vargas R; Grasela D; Wang Z Drugs R D; 2007; 8(1):43-50. PubMed ID: 17249848 [TBL] [Abstract][Full Text] [Related]
11. Effect of an enteral nutrient formula on sustained-release theophylline absorption. Bhargava VO; Schaaf LJ; Berlinger WG; Jungnickel PW Ther Drug Monit; 1989 Sep; 11(5):515-9. PubMed ID: 2510372 [TBL] [Abstract][Full Text] [Related]
12. Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability. Gatti G; Bartoli A; Marchiselli R; Michelucci R; Tassinari CA; Pisani F; Zaccara G; Timmings P; Richens A; Perucca E Br J Clin Pharmacol; 1993 Dec; 36(6):603-6. PubMed ID: 12959280 [TBL] [Abstract][Full Text] [Related]
13. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate. Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of an elemental and a complex enteral feeding formulation on the absorption of phenytoin suspension. Marvel ME; Bertino JS JPEN J Parenter Enteral Nutr; 1991; 15(3):316-8. PubMed ID: 1907681 [TBL] [Abstract][Full Text] [Related]
15. Effect of antacids on phenytoin bioavailability. Carter BL; Garnett WR; Pellock JM; Stratton MA; Howell JR Ther Drug Monit; 1981; 3(4):333-40. PubMed ID: 7336470 [TBL] [Abstract][Full Text] [Related]
16. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas. Fay MA; Sheth RD; Gidal BE Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308 [TBL] [Abstract][Full Text] [Related]